Brookfield Acquires More Than 50% Shares And Voting Rights In Alstria Office REIT – Quick Facts

Herald morning quiz: January 13

Test your brains with the Herald’s morning quiz. Be sure to check back on for the afternoon quiz.

To challenge yourself with more quizzes, CLICK HERE.

ALDI Recalls Pure Being Pet Advent Calendars

Retailer ALDI U.S., along with Pet Brands Products, LLC, is recalling certain Pure Being Pet Advent Calendars citing potential choking hazard, the U.S. Food and Drug Administration said.

The recall involves Pure Being Cat Advent Calendars with UPC 4099100267754 and Pure Being Dog Advent Calendars with UPC 4099100267747. The products come in 5.15 oz boxes. No other ALDI products are affected by the recall.

The recall was initiated after receiving a small number of customer complaints. ALDI, which operates more than 2,100 stores across 37 states, immediately removed the affected products from stores after discussing with the supplier.

Customers are urged to discard the products immediately or return it to their local store for a full refund.

In recent recalls involving pet products, Livia Global, Inc., a health and wellness company, in early December called back BioLifePet Probiotics for cats and BioLifePet Probiotics for dogs citing the possibility of contamination by Pseudomonas aeruginosa.

PetSmart Home Office Inc. in early September recalled about 100,300 units of Top Paw Double Diner Dog Bowls for laceration concerns.

51job: Special Committee To Evaluate Proposed Revised Transaction From Garnet Faith

51job, Inc. (JOBS) said its Board and the special committee have received a proposal letter from Garnet Faith Limited in connection with the proposed merger. In the proposal letter, Garnet Faith Limited proposed to reduce the merger consideration from $79.05 in cash per common share to $57.25 in cash per common share and reduce the combined ownership of DCP Capital Partners II, L.P. and Ocean Link Partners Limited in 51job upon consummation of the proposed merger to 9.99%.

51job said the special committee will evaluate the proposed amendments in light of the latest development with the assistance of its financial and legal advisors.

Tivic Health Systems Shares Gain 7%, Downtick Ends

Shares of nano-cap company Tivic Health Systems, Inc. (TIVC) are gaining over 7% on Tuesday morning after dropping to a month-long low on Monday. The company has not reported any stock-related news to drive the shares.

TIVC is currently trading at $3.0381, up $0.2081 or 7.35%, on the Nasdaq. The stock has traded between $2.63 and $6.50 in the 52-week period. Yesterday, the stock had closed at $2.83, which was down 35% in the past one-month period.

Tivic Health Systems operates as a bioelectronic device company that delivers non-invasive neuromodulation products for the treatment of inflammatory conditions. The company’s primary product, ClearUP, is a medical device intended to relieve sinus and nasal inflammation.

Immix Biopharma Spikes After IMX-110 Surpasses Standard Of Care In Mice Model

Immix Biopharma, Inc. (IMMX) shares are soaring more than 25 percent on Wednesday morning trade after the company reported a positive response for its lead candidate IMX -110 in first-line – therapy-resistant cancer, surpassing the standard of care in mice model.

The biopharma company said IMX-110 produced a 50 percent response rate after 1 cycle of treatment as a monotherapy in the first line-therapy-resistant cancer – soft tissue sarcoma mice study.

The FDA has approved orphan drug designation for IMX-110 for the treatment of soft tissue sarcoma and was already approved rare pediatric disease designation to IMX-110 for the treatment of a life-threatening pediatric cancer in children, rhabdomyosarcoma.

Immix shares are currently at $6.76, up 22.85 percent from the previous close of $5.43 on a volume of 34,851,822. For the 52-week period, the shares have traded in a range of $2.85-$8.68 on average volume of 16,116,929.

InMode Shares Rise 3% On Preliminary Q4, FY21 Results

Shares of medical technologies provider InMode Ltd (INMD) are up 3 percent on Wednesday’s trading after the company provided preliminary results for its fourth quarter and full year 2021.

The company expects fourth-quarter adjusted earnings between $0.61 and $0.62 per share and revenues between $109.5 million and $110 million.

For full-year 2021, the company anticipates adjusted earnings between $2.02 and $2.03 and revenues between $3356.5 million and $357 million, higher than the earlier announced guidance of $343 million and $347 million.

Currently trading at $55.70, the stock has traded between $26.38 and $99.27 during the past 52 weeks.

11 Macaroni and Cheese Recipes to Curl Up With on the Couch

When in doubt, coat noodles in cheese sauce and call it dinner.

Send any friend a story

As a subscriber, you have 10 gift articles to give each month. Anyone can read what you share.

By Becky Hughes

Brookfield Acquires More Than 50% Shares And Voting Rights In Alstria Office REIT – Quick Facts

Brookfield Asset Management Inc. (BAM) on Wednesday acquired a total of 89.90 million shares and voting rights (50.50% of the issued share capital) of Germany-based REIT alstria office REIT AG. After settlement of the takeover offer, Brookfield will own indirectly more than 50% of the voting rights and the shares of alstria.

Subject to the fulfilment of all offer conditions of the takeover offer, these shares and voting rights in alstria are attributed, inter alia, to Brookfield Asset Management.